trial · primary record
ANO31905
Pancreatic Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 84 |
| Primary completion | 2028-12 |
| Primary endpoint | Dose-limiting toxicity (DLT) (Phase Ib). |
| Registry ID | NCT07444541 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:42.829Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07444541
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.